Padraic O'Malley
CHIEF & CLIN ASO PROF
MD-UROLOGY
GRANTS
- GRANTA Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel Formulation of UGN-101, for the Treatment of Patients With Low-grade Upper Tract Urothelial Cancer (LG-UTUC)Urogen Pharma Ltd12 Sep 2025 - 11 Sep 2030
- GRANTA Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)Cg Oncology24 Jun 2025 - 23 Jun 2030
- GRANTGAIN-BCG: Gemcitabine Alternating with INtravesical BCG randomized against BCG alone for patients with recurrent high grade Non-Muscle Invasive Bladder CancerNational Institute of Health Nci5 Jun 2025 - 28 Feb 2029
- GRANTSalvage Focal Therapy via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer (FocalHIFU) (NCT06402357)Edap Technomed18 Nov 2024 - 17 Nov 2029
- GRANTa multi- center registry under a protocol entitled “uTRACT Registry Jelmyto® (mitomycin) for pyelocalyceal solution (the “Drug”)Urogen Ltd6 Aug 2024 - 5 Aug 2029
- GRANTA Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder CancerSurge Therapeutics9 May 2024 - 8 May 2029
- GRANTA Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)National Institute of Health Nci5 Jan 2023 - 28 Feb 2029
- GRANTPivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient PopulationAngiodynamics25 Apr 2022 - 30 Jan 2024
- GRANTPivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient PopulationAngiodynamics25 Apr 2022 - 13 May 2025
- GRANTA 3-arm randomized controlled trial evaluating the role of 29MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancerExact Imaging6 Apr 2022 - 16 May 2025
- GRANTA 3-arm randomized controlled trial evaluating the role of 29MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancerExact Imaging6 Apr 2022 - 4 May 2026
- GRANTPhase III Trial of Immunotherapy-Based Combination Therapy with or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE trial)National Institute of Health Nci16 Nov 2020 - 28 Feb 2029